Fidelity Select Pharmaceuticals Portfolio FPHAX

Morningstar Medalist Rating
  • NAV / 1-Day Return$38.08  /  −1.35%
  • Fund Size$1.8B
  • Adjusted Expense Ratio0.670%
  • Net Expense Ratio0.670%
  • Fee Level: DistributionLow
  • Share Class TypeNo Load
  • Morningstar CategoryHealth
  • Equity Style Box (Funds)Large Value
  • Minimum Initial Investment$0
  • Investment StatusOpen
  • TTM Yield2.30%
  • Turnover Ratio77%

Morningstar’s Analysis FPHAX

Will FPHAX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Fidelity Select Pharmaceuticals Port holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FPHAX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings73.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

25.35408M
Healthcare

GSK PLC ADR

8.10130M
Healthcare

Viatris Inc

5.9496M
Healthcare

Merck & Co Inc

5.8694M
Healthcare

AstraZeneca PLC

4.9480M
Healthcare

Bristol-Myers Squibb Co

4.8278M
Healthcare

Gilead Sciences Inc

4.6274M
Healthcare

Moderna Inc

4.6074M
Healthcare

UCB SA

4.5473M
Healthcare

Roche Holding AG Ordinary Shares new

4.4371M
Healthcare

Sponsor Center